ID   SK-N-AS RET KO clone C5
AC   CVCL_C0QB
SY   SK-N-AS C5
DR   ArrayExpress; E-MTAB-10032
DR   cancercelllines; CVCL_C0QB
DR   PRIDE; PXD024551
DR   Wikidata; Q112930403
RX   PubMed=33921066;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 9967; RET.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=33921066; DOI=10.3390/cancers13081909;
RA   Siaw J.T., Gabre J.L., Uckun E., Vigny M., Zhang W.-C.,
RA   Van den Eynden J., Hallberg B., Palmer R.H., Guan J.-K.;
RT   "Loss of RET promotes mesenchymal identity in neuroblastoma cells.";
RL   Cancers (Basel) 13:1909.1-1909.25(2021).
//